Gabelli Funds LLC Bioventus Inc. Transaction History

Gabelli Funds LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.89 - $5.34 $23,120 - $42,720	-8,000 Reduced 44.44%	10,000 $52,000
Q3 2023 Nov 08, 2023	SELL	$2.8 - $4.94 $14,559 - $25,688	-5,200 Reduced 22.41%	18,000 $59,000
Q1 2023 May 12, 2023	SELL	$1.07 - $2.95 $1,712 - $4,720	-1,600 Reduced 6.45%	23,200 $24,000
Q4 2022 Feb 13, 2023	SELL	$1.81 - $8.14 $1,810 - $8,140	-1,000 Reduced 3.88%	24,800 $64,000
Q2 2022 Aug 12, 2022	BUY	$6.82 - $13.82 $4,092 - $8,292	600 Added 2.38%	25,800 $176,000
Q1 2022 May 13, 2022	SELL	$11.65 - $15.28 $14,329 - $18,794	-1,230 Reduced 4.65%	25,200 $355,000
Q4 2021 Feb 11, 2022	BUY	$12.37 - $16.77 $326,939 - $443,231	26,430 New	26,430 $383,000

143

45.9M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $659M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.